Mike FS Stone

Prospector Partners LLC (Prospector) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Guilford, Connecticut. The firm was founded in 1997 by John D. Gillespie. Prospector provides discretionary investment management services to various institutional clients, which includes, but not limited to, private investment funds, a registered investment company, insurance companies, and other corporate or institutional entities.

ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.

Welltok, Inc. is a consumer activation solutions company that improves people's total wellbeing. It offers proprietary data, advanced analytics, software-as-a-service software, and professional services to engage consumers in personalized and rewarding ways to drive action. The company was founded Jeff Cohen, Carlos C. Cardona, Scott Rotermund, Chris Rotermund, Christopher Coloian, Stanley J. Nowak III, Paulo Matos, Patrick D. Mize, and John DiBiasi in 2009 and is headquartered in Denver, CO.

TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom.

PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom.

QUALCOMM Ventures (QUALCOMM Ventures) is a venture capital subsidiary of QUALCOMM, Inc. The firm is headquartered in San Diego, California.

dRx Capital AG (dRx Capital) is a investment arm of Novartis AG founded in 2015 by Valencia Rick. The firm is headquartered in Cambridge, Massachusetts.

Carbicrete, Inc. is a Canadian Montreal-based carbon removal technology company that produces cement-free, carbon-negative concrete using industrial by-products and captured carbon dioxide. The company is based in Lachine, Canada. The company's patented process abates/ removes 150 kg of CO2 for every ton of concrete produced. Carbicrete concrete offers the same or better quality and performance as traditional concrete, but with a carbon-negative footprint. The company was founded by Chris Stern and Mehrdad Mahoutian, and Chris Stern has been the CEO since incorporation.

Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan.

Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan.